📈 Will you get serious about investing in 2025? Take the first step with 50% off InvestingProClaim Offer

Abingdon Health opens new analytical lab in Doncaster

Published 17/12/2024, 07:12

YORK, U.K. - Abingdon Health plc (AIM: ABDX), a prominent international contract development and manufacturing organization (CDMO), has announced the inauguration of its analytical laboratory situated in Doncaster, operated by its fully-owned subsidiary, Abingdon Analytical Ltd.

The new laboratory is part of the company's strategic expansion to bolster its comprehensive CDMO services, which assist customers in navigating products to market. Abingdon Analytical Ltd will cater to the lateral flow testing market and adjacent sectors, delivering critical services such as product stability testing and sensitivity assessment, all of which are essential for regulatory approvals by authorities like the FDA, EU IVDR, and UKCA.

The opening of this facility follows the company's investment of up to £1 million from recent fundraising efforts. This investment aims to enhance the Group's analytical laboratory services, which in turn supports its regulatory service offerings.

Dr. Chris Hand, Executive Chairman of Abingdon Health, stated that the addition of the analytical laboratory underscores the company's commitment to providing a bridge between its CDMO and regulatory services. The laboratory is designed to generate analytical and product performance data for regulatory technical files, augmenting the broad portfolio of services offered to customers. Dr. Hand also highlighted the announcement of a major contract, which exemplifies the advantages of integrating analytical capabilities into the company's CDMO offerings.

Abingdon Health Group is recognized for its Medtech contract services delivered to an international clientele. The company specializes in lateral flow product development, regulatory support, and large-scale manufacturing. It also provides regulatory services through Compliance Solutions (Life Sciences) and IVDeology, offering a wide range of support to the in vitro diagnostic and medical device industry.

This development is expected to enhance Abingdon Health's position as a comprehensive service provider in the medical device sector. The information for this article is based on a press release statement.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.